In addition, GLP-1 delays stomach emptying, suppresses appetite, inhibits glucagon secretion, and slows glucose production in the liver
Can GLP-1 drugs lower cancer risk
Similar content being viewed by others Subjects Introduction Discovery of the so called incretin effect, where ingested glucose leads to enhanced insulin release compared to intravenous glucose administration, revealed the existence of insulin release factors in the gut 1
This product is not intended to diagnose, treat, cure or prevent any disease
GLP-1 medications may cause serious side effects
There are several types of GLP medications that engage different types of glucagon receptors, giving them different effects in different people: Single receptor agonists (GLP-1 only): Ozempic, Wegovy, Saxenda Dual receptor agonists (GLP-1 + GIP): Mounjaro, Zepbound Triple receptor agonists (GLP-1 + GIP + glucagon): in development early studies show even greater metabolic effects These medications are changing how we are able to ameliorate obesity, food addiction, insulin resistance, and cardiometabolic risks